Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Omacor - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

Omacor

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Reliant Pharmaceuticals, Inc., Liberty Corner, NJ, and Pronova Biocare AS, Oslo, Norway, have reached an agreement for Reliant to market Omacor (omega 3 acid ethyl esters) in the U.S. following the product’s recent approval by FDA. Under the terms of the agreement, Reliant will have exclusive marketing and distribution rights in the U.S. and will maintain the New Drug Application (NDA). Omacor, which contains highly concentrated ethyl esters of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), was approved by the FDA on November 10, 2004, as an adjunct to diet for the reduction of triglycerides in adult patients with very high triglyceride levels (greater than or equal to 500 mg/dL).

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters